chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient did not experience any adverse reactions or signs/symptoms due to given vaccine the dorsogluteal. Pt has very low muscle mass as to why the vaccine was given in that muscle instead of the preferred sites at that time. It was requested by the  local DOH to submit this report.
Patient developed a large bump - raised area approximately 8 cm in diameter - reported by nurse to us where patient is assumed to work. No itching or hives. Looked like a spider bite. Starting to recovery 06/23/2016.
Fever has been steadily rising in spite of Motrin, it's now at 103, and 103.5; This is a spontaneous report from a contactable consumer (patient's parent). A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient previously took bnt162b2 (BNT162B2), dose 1 single for covid-19 immunization. The patient experienced fever has been steadily rising in spite of motrin, it's now at 103, and 103.5 (on an unspecified date with outcome of unknown.The patient underwent lab tests and procedures which included body temperature: 103 on unspecified date, body temperature: 103.5 on unspecified date, body temperature: 104 fahrenheit on unspecified date. Reporter stated, that the daughter got her second dose of COVID 19 vaccine yesterday, and her fever yesterday at 4 or 4:10 something like that, and her fever has been steadily rising in spite of Motrin, it's now at 103, and 103.5. And felt really concerned if something that was normal, and queried if the daughter needs to be taken to the hospital, or what else need to done?"Reporter stated her daughter was having almost 104 (degree Fahrenheit) fever with the vaccine on the second dose (Unspecified vaccine) and I wanted to check whether that's, can be very high, The reporter that stated that one can get heat up' but (incomplete sentence).Therapeutic measures were taken as a result of fever has been steadily rising in spite of motrin, it's now at 103, and 103.5 (pyrexia).The outcome of the event was unknown.
Patient presented to the office on 5/18/2021. Reported  dyspnea, fluid retention, loss of appetite, and a cough productive of clear phlegm.  The symptoms began after receiving his 2nd COVID vaccine on May 5th.  Patient was tachycardic, tachypneic, and had prominent S3 gallop,, CXR  significant for cardiomegaly.. An echocardiogram dated 5/21/2021 demonstrates severe left ventricular dysfunction with and EF of 25% and moderately reduced right ventricular systolic dysfunction.
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
starting to get anxiety about it; little nervous with chills and crap; chills; fever; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient).   A 65-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch no: not reported/Lot number: EW0153) via an unspecified route of administration, administered in Left arm on 20Apr2021 (age at the time of vaccination was 65 years old) as a dose 2, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had no family medical history Relevant to AE. Historical vaccine included previously, the patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch no: not reported/Lot number: EP6955) via an unspecified route of administration, administered in Left arm on 22Mar2021 (age at the time of vaccination was 65 years old) as a dose 1, single dose for COVID-19 immunization and experienced his arm got sore and it made the caller sleepy. No Prior Vaccinations taken within 4 weeks. No adverse events following prior vaccinations. After the second dose on an unspecified date in Apr2021, the patient experienced with systemic side effects like chills and fever were observed within the first 1 to 2 days after receiving the vaccine and that have lasted 7 days now, it was ongoing and has worsened, constantly back-to-back. On an unspecified date, patient was starting to get anxiety and a little nervous with chills and crap. Patient was asking about how long the reported events that supposed to last. Investigation Assessment was provided as No. AE did not require a visit to Emergency room or Physician office. Relevant Tests were reported as none. Patient was referred to his physician for treatment recommendation. The clinical outcome of chills and fever was not recovered and starting to get anxiety about it, little nervous with chills and crap was unknown.   No follow-up attempts are needed. No further information is expected.
CLIENT CALLED AND LEFT A MESSAGE ON 10/5/2020 TO CANCEL SECOND DOSE SHINGRIX DUE TO A REACTION FROM THE FIRST DOSE.  CALLED AND TALKED TO CLIENT ON 10/6/2020.  CLIENT WAS GIVEN SHINGRIX ON 8/5/2020.  CLIENT STATED THAT ON 8/72020 SHE HAD A RASH ON HER CHEST THAT WENT UP ONTO HER NECK.  SHE ALSO STATED THAT SHE STARTED TO WHEEZE SO TOOK ALLERGY MEDICATION WHICH HELPED.  SHE THEN STATED THAT THAT NIGHT SHE HAD AN ASTHMA ATTACK AND HAD TO USE HER EMERGENCY INHALER THAT SHE HAS FOR HER ASTHMA.  HER CONDITION IMPROVED AND NO FURTHER TREATMENT WAS NEEDED.  SHE SPOKE WITH HER PRIMARY PROVIDER AND HER PROVIDER STATED THAT SHE SHOULDN'T GET THE SECOND DOSE DUE TO A REACTION AND STATED THAT SHE IS A ALLERGIC TO THE VACCINE AND SHOULDN'T GET ANYMORE.  THE CLIENT HAS DECIDED NOT TO GET THE SECOND DOSE OF SHINGRIX.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Dec2021 as dose 2 (booster), single (Batch/Lot number: unknown) at the age of 36 years, in right arm for covid-19 immunisation; janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), on 17Mar2021 as dose 1, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SYNTHROID; METFORMIN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received the Pfizer vaccine on 1/26/21, 2/15/21 and 8/26/21 so was fully vaccinated and had received a third dose when they tested positive for COVID-19 on 9/20/21.
Shot was given secondary to recommendation chart.  Upon physicians review it was determined that due date was at 12 months.  Our office contacted a representative who advised us that as long as there was no reactions this would not be a problem other than mother would have to get shot again for child at appropriate time.
Woke up with chills and tense pain in long bones. Never experienced long bone pains like that. It was very unusual. He has taken tylenol and motrin which has made it get gradually better.
Intense vertigo started 4 days later; significant dizziness, feeling room spinning, throwing up every time I stood up, confusion, muffled hearing in right ear,  nausea, diarrhea.
Post-HepA, MMR, varicella & flue immunization, red truncal papular rash with fever 11 days post vaccines.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.            No concomitant medications was provided by the reporter. No treatment medications was provided by the reporter.
Ulnar nerve swelling causing entrapment at left elbow and wrist. Loss of sensation left ulnar nerve distribution 2 days after first vaccine. EMG demonstrated demyelinated neve with conduction velocity of 17 m/s. Loss of sensation. Motor weakness.
No adverse effects; one separate dose of an improperly stored vaccine, PEDVAXHIB was administered to one separate patient.; Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.    On 17-JUN-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) 0.5 milliliter (one dose, lot# R021077, expiration date: 11-JUN-2021, frequency was unknown) intramuscularly for prophylaxis (incorrect product storage). No adverse effect was reported.  The vaccines were exposed to temperature of 34.2 Fahrenheit (F) for 4 hour 54 minutes. The temperature excursion was detected by a data logger. No previous excursions were reported.  This is one of several reports from the same reporter. ; Sender's Comments:  US-009507513-1906USA011674:
Felt a bit dizzy and tired. These continued with inability to securely grasp things with my left hand until Saturday March 20th when I was taken to the ER.
Pt spouse called reports, pt has 103 degree temp after Flu shot 11-29-12 c/o HA body ache.
c/o tingling in left shoulder that radiated down to the hands; reported that hands felt warm and then developed a mild headache.  Remained with patient for 20 minutes post vaccine; stated she was "fine" and that symptoms were dissipated.  Instructed to repeat Tylenol and take Benadryl prophylactically.  Assisted in setting up an account in the program.
I developed tinnitus several days after the vaccine. I can't be sure how many days later because I ignored it at first. It took me a while to realize it could be connected to the vaccine.  Low level hissing is fairly constant and once in a while a high-pitched whine. I've never had tinnitus before. I'm going for my second COVID vaccine tomorrow.
Gave immuni. Pt. felt faint, laid back and lost consciousness had a seizure lasting about 1 minute. Regained consciousness but faint, weak, nauseated, sweating. Called 911 when seizure started. They arrived established low blood pressure and fainting upon standing, transported to hospital. Pt received three immunizations: TYPHIM VI and BOOSTRIX in the left deltoid IM and HAVRIX in the right deltoid IM. Immediately following the HAVRIX injection while removing my gloves, patient commented that she felt faint. I told her to stay in the chair and relax for a moment. She lost consciousness, her eyes rolled back and she went into a seizure with body contractures. I braced her in the chair as she was sliding out, opened the door and yelled for the technician to call 911. The seizure lasted about one minute after which she regained consciousness but was in and out like falling asleep but able to be awaken when nudged and talked to. She reported feeling weak, faint, nauseated. She was sweating. I was unable to get blood pressure through sweatshirt and did not want to move her to remove sweatshirt fearing another seizure. I dabbed to forehead and cheeks with wet paper towels. I maintained her attention by talking with her. She had brought a friend with her and he also talked with her. I provided her with some water to sip on when she reported she was thirsty. While waiting for EMS she commented that she felt better and wanted to go home and take a nap. I convinced her to at least get checked out first. When they were arrived I relayed all information to them. They were able to get blood pressure readings that were around 89/45. They tried to stand her up to get another reading it was around 47/29 and she fainted again, regaining consciousness immediately. They removed her sweatshirt and they transported her to the hospital immediately.
Since I had the first shot,  I have had stomach pain and couching is huritng my adominal area.
I have my right wrist and elbow have been swelled and are sore to touch, with limited movement; I have my right wrist and elbow have been swelled and are sore to touch, with limited movement; My left shoulder is sore and painful all the time; Fatigue is every night; DOSE 1, 2, 3 : Moderna and DOSE 4: BNT162B2; DOSE 1, 2, 3 : Moderna and DOSE 4: BNT162B2; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09May2022 at 16:45 as dose 4 (booster), single (Lot number: Fm0173) at the age of 60 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; LOSARTAN; AMLODIPINE; PRAVASTATIN. Past drug history included: Morphine, reaction(s): "Known allergies: Morphine", notes: Known allergies: Morphine. Vaccination history included: moderna (DOSE 1; Lot number: 032H02A; Anatomical Location:Arm Left, Time of administration: 04:45 PM), administration date: 06Jan2021, when the patient was 58-year-old, for COVID-19 immunization; moderna (DOSE 2; Lot number: 032H02A; Anatomical Location:Arm Left, Time of administration: 04:45 PM), administration date: 03Feb2021, when the patient was 58-year-old, for COVID-19 immunization; moderna (DOSE 3; Lot number:939906; Anatomical Location:Arm Left, Time of administration: 04:45 PM), administration date: 04Nov2021, when the patient was 59-year-old, for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), OFF LABEL USE (non-serious) all with onset 09May2022 at 16:45, outcome "unknown" and all described as "DOSE 1, 2, 3 : Moderna and DOSE 4: BNT162B2"; FATIGUE (non-serious) with onset 14May2022, outcome "not recovered", described as "Fatigue is every night"; JOINT SWELLING (non-serious), MOVEMENT DISORDER (non-serious) all with onset 14May2022, outcome "not recovered" and all described as "I have my right wrist and elbow have been swelled and are sore to touch, with limited movement"; ARTHRALGIA (non-serious) with onset 14May2022, outcome "not recovered", described as "My left shoulder is sore and painful all the time". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of joint swelling, movement disorder, arthralgia, fatigue.  Additional information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19. Device date was provided as 20Jun2022.
This initial spontaneous case, was received on 25-Oct-2017, reported by other non-health professional, concerning a 16-year-old, adolescent, female patient. The patient's medical history and concomitant medications were not reported. On 25-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 195227, expiry date: May-2018). On the same day, 2 hours after vaccination, the reporter stated that, the patient developed hives all over her body. It was also reported that, the patient had no difficulty in breathing. No treatment measures were given to the patient. At the time of this report, the patient had not recovered from the event. The reporter assessed this case as non-serious.
Pt developed fever to 104. Fever continued for 3 day then rash appeared. C/w Roseola.
CAN'T FOCUS; DECREASED MUSCLE MOVEMENT; ARM PAIN; CAN'T PICK UP A JUG OF MILK; HEADACHE; MUSCLE PAIN; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 25-JUN-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 03-JUL-2021, the subject experienced can't focus. On 03-JUL-2021, the subject experienced decreased muscle movement. On 03-JUL-2021, the subject experienced arm pain. On 03-JUL-2021, the subject experienced can't pick up a jug of milk. On 03-JUL-2021, the subject experienced headache. On 03-JUL-2021, the subject experienced muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, can't focus, muscle pain, arm pain, decreased muscle movement, and can't pick up a jug of milk. This report was non-serious.
10:39 am.  Sudden onset of dizziness, diaphoresis and blurred vision.  Immediate evaluation by onsite EMS and NP. BO 110/64;HR 49; Provided water, snack - symptoms improved. She stated she had waited in line > 1 hr outside. VS@10:46: 132/73;HR 64.  Feels much better.  Discharged to home @ 10:50.
coughing/coughs so much until he throws up; nose runs; while he is coughing he is drooling; he feels dizzy when standing; about to pass out; whole face gets numb; coughs so much until he throws up; breathing has been the pits / He has been getting worse shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (breathing has been the pits / He has been getting worse shortness of breath), COUGH (coughing/coughs so much until he throws up), RHINORRHOEA (nose runs), DROOLING (while he is coughing he is drooling) and DIZZINESS POSTURAL (he feels dizzy when standing) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DYSPNOEA (breathing has been the pits / He has been getting worse shortness of breath). On an unknown date, the patient experienced COUGH (coughing/coughs so much until he throws up), RHINORRHOEA (nose runs), DROOLING (while he is coughing he is drooling), DIZZINESS POSTURAL (he feels dizzy when standing), PRESYNCOPE (about to pass out), HYPOAESTHESIA (whole face gets numb) and VOMITING (coughs so much until he throws up). The patient was treated with ALBUTEROL [SALBUTAMOL] at an unspecified dose and frequency. At the time of the report, DYSPNOEA (breathing has been the pits / He has been getting worse shortness of breath), COUGH (coughing/coughs so much until he throws up), RHINORRHOEA (nose runs), DROOLING (while he is coughing he is drooling), DIZZINESS POSTURAL (he feels dizzy when standing), PRESYNCOPE (about to pass out), HYPOAESTHESIA (whole face gets numb) and VOMITING (coughs so much until he throws up) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication were reported. Since receiving the first dose of the Moderna vaccine, breathing "has been the pits. Patient had been getting worse shortness of breath since then. Patient also sometimes felts a sensation when coughing like and was about to pass out. The patient had been in and out of the emergency room and urgent care. Patent has been taking albuterol, "the pump," and breathing treatments with a machine which helps for about 30 minutes. The patient had put in a request for an oxygen machine, but had not received that yet.   This case was linked to MOD-2022-516667, MOD-2022-516898 (Patient Link).
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-JUL-2022.; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-JUL-2022.) and NO ADVERSE EVENT (No adverse event) in a 47-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-JUL-2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-JUL-2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 19-JUL-2022.).    No concomitant product use was reported. Patient received half dose. On 04-Jun-2022 the vials were initially stored in the refrigerator. Vial did not undergone any temperature excursions. No treatment information was provided.
Period started 16 days early with none of my usual PMS symptoms and was unusually painful and heavy
On Saturday, February 13, I began to experience severe headaches for a week, and then excruciating pain in my temples and under my chin when biting into a sandwich and chewing food.  On February 23, I visited my Dr. and he said he could not give me anything for the pain because it would affect the antibodies.  On March 2, I visited my internist, Dr.  He did a SED test and found excessive inflammation.  On Saturday, March 6, I woke up with lost vision.  Was sent for an MRI at the Hospital.  Entered  the Hospital that night and was given 1 gram of IV solumedrol for 4 days.   Biopsy was positive for GCA.  I am on100 mg of Prednizone daily and have been referred to a neuroopthalmologist.
Middle left back pain with radiation to the left leg all the way to the toes. Complains of numbness of big toe to the middle toe.